(Q33422275)

26 July 2017

title

Time-to-signal comparison for drug safety data-mining algorithms vs. traditional signaling criteria (English)

1 reference

26 July 2017

0 references

A M Hochberg

1

1 reference

26 July 2017

M Hauben

series ordinal

2

1 reference

26 July 2017

language of work or name

English

0 references

publication date

25 March 2009

1 reference

Clinical Pharmacology & Therapeutics

26 July 2017

published in

1 reference

26 July 2017

volume

85

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

600-606

1 reference

Novel statistical tools for monitoring the safety of marketed drugs

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

Perspectives on the use of data mining in pharmaco-vigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

Anecdotes that provide definitive evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

Trimethoprim-induced hyperkalaemia -- lessons in data mining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

Effect of consumer reporting on signal detection: using disproportionality analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

Drug-induced pancreatitis: lessons in data mining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

Improving detection of adverse effects of marketed drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

7 January 2021

Practical pharmacovigilance analysis strategies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

7 January 2021

Signal Selection and Follow-Up in Pharmacovigilance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

7 January 2021

Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

7 January 2021

Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

7 January 2021

Signal detection in pharmacovigilance: empirical evaluation of data mining tools

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.26

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.26

1 reference

release_qtkce4p6qfcrhdk2iyjlpzdibe

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qtkce4p6qfcrhdk2iyjlpzdibe

24 November 2022

mapped directly with Wikidata item

1 reference